Analysis on the adoption rate and influencing factors of electronic medication monitors in tuberculosis patients in Jilin Province

doi:10.19982/j.issn.1000-6621.20220080

Abstract

Abstract:

Objective:According to the acceptance of electronic medication monitors (EMM) after its comprehensive promotion in Jilin Province, analyze the relevant factors affecting the adoption rate of EMM. Methods:Collect the medical record data about adoption of EMM among tuberculosis patients registered in Jilin Province in 2019 at different times, in different regions and with different characteristics. Univariable and multivariable logistic regression models were used to analyze the current status and influencing factors of EMM usage in tuberculosis patients. Results:In 2019, 8435 tuberculosis patients were registered in the EMM promotion regions, and 5231 patients accepted EMM management, the adoption rate of EMM was 62.02%. Multivariable logistic regression analysis showed that patients being 20-39 years old (OR=1.264, 95%CI: 1.026-1.558) or 40-59 years old (OR=1.280, 95%CI: 1.045-1.567), non-Han ethnic groups (OR=2.176, 95%CI: 1.691-2.801), with an occupation farmer or herdsman (OR=1.189, 95%CI: 1.081-1.308), local patients (OR=3.425, 95%CI: 2.968-3.952), patient coming from referral or tracking (OR=1.747, 95%CI: 1.588-1.921), etiologically positive (OR=3.437,95%CI:2.779-4.250) or negative (OR=3.454,95%CI:2.790-4.278) patients, newly treated patients(OR=3.024, 95%CI: 2.511-3.642) got a higher rate of using EMM. Conclusion:As a tool for supervision of medication for patients, EMM can be popularized and used in Jilin Province, especially for patients aged 20-59, farmers and herdsmen, local registered residence patients, patients coming from referral and tracking, etiologically positive and negative patients and newly treated patients.

Key words: Tuberculosis,pulmonary, Electronic medication monitors, Diffusion of innovation, Health services administration, Factor analysis,statistical

CLC Number:

R521

Yang Fan, Ma Jianjun, Gao Ying, Gao Zhihui, Yuan Yanli. Analysis on the adoption rate and influencing factors of electronic medication monitors in tuberculosis patients in Jilin Province[J]. Chinese Journal of Antituberculosis, 2022, 44(10): 1050-1056. doi: 10.19982/j.issn.1000-6621.20220080

Figures/Tables 7

季度	登记例数	使用例数	使用率(%)	$χ 趋势 2$ 值	P值
第一季度	2372	1298	54.72	174.750	<0.001
第二季度	2227	1627	73.06
第三季度	1998	1199	60.01
第四季度	1838	1107	60.23
合计	8435	5231	62.02

特征	β值	S $x ¯$ 值	Wald χ²值	P值		OR(95%CI)值
年龄组(岁)
3~19			11.217	0.011		1.000
20~39	0.235	0.106	4.858	0.028		1.264(1.026~1.558)
40~59	0.247	0.103	5.687	0.017		1.280(1.045~1.567)
60~95	0.106	0.106	1.007	0.316		1.112(0.904~1.368)
民族
汉族						1.000
少数民族	0.778	0.129	36.550	<0.001		2.176(1.691~2.801)
职业
非农牧民						1.000
农牧民	0.173	0.049	12.679	<0.001		1.189(1.081~1.308)
户籍地^a
外地						1.000
本地	1.231	0.073	284.143	<0.001		3.425(2.968~3.952)
患者来源
因症检查^b			149.630	<0.001		1.000
转诊追踪	0.558	0.049	132.040	<0.001		1.747(1.588~1.921)
其他来源^c	-0.158	0.103	2.344	0.126		0.854(0.697~1.045)
诊断结果
其他结果^d			136.610	<0.001	1.000
病原学阳性^e	1.235	0.108	129.656	<0.001	3.437(2.779~4.250)
病原学阴性	1.240	0.109	129.245	<0.001	3.454(2.790~4.278)
治疗分类
复治					1.000
初治	1.107	0.095	136.033	<0.001	3.024(2.511~3.642)

References 15

[1]	谭守勇. 应重视抗结核药物性肝损伤的防治. 中华结核和呼吸杂志, 2019, 42(5):326-329. doi: 10.3760/cma.j.issn.1001-0939.2019.05.003. doi: 10.3760/cma.j.issn.1001-0939.2019.05.003
[2]	Tesfahuneygn G, Medhin G, Legesse M. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes, 2015, 8:503. doi: 10.1186/s13104-015-1452-x. doi: 10.1186/s13104-015-1452-x pmid: 26420164
[3]	吴波. 结核病患者治疗管理新技术的应用与进展. 中国防痨杂志, 2019, 41(10):1136-1140. doi: 10.3969/j.issn.1000-6621.2019.10.014. doi: 10.3969/j.issn.1000-6621.2019.10.014
[4]	World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization, 2014.
[5]	张铁娟, 潘艳, 马建军, 等. 医疗保险支付新模式减轻肺结核患者经济负担的效果分析. 中国防痨杂志, 2021, 43(8): 778-782. doi: 10.3969/j.issn.1000-6621.2021.08.005. doi: 10.3969/j.issn.1000-6621.2021.08.005
[6]	王倪, 张慧, 张铁娟, 等. 使用电子药盒辅助肺结核患者服药管理的实施情况分析. 中国防痨杂志, 2020, 42(7): 682-686. doi: 10.3969/j.issn.1000-6621.2020.07.008. doi: 10.3969/j.issn.1000-6621.2020.07.008
[7]	王倪, 黄飞, 张慧. 电子药盒在结核病患者服药管理中的应用与进展. 结核病与肺部健康杂志, 2019, 8(4):244-248. doi: 10.3969/j.issn.2095-3755.2019.04.003. doi: 10.3969/j.issn.2095-3755.2019.04.003
[8]	Hou WL, Song FJ, Zhang NX, et al. Implementation and community involvement in DOTS strategy: a systematic review of studies in China. Int J Tuberc Lung Dis, 2012, 16(11):1433-1440. doi: 10.5588/ijtld.12.0080. doi: 10.5588/ijtld.12.0080 pmid: 23044444
[9]	Liu X, Lewis JJ, Zhang H, et al. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial. PLoS Med, 2015, 12(9):e1001876. doi: 10.1371/journal.pmed.1001876. doi: 10.1371/journal.pmed.1001876 URL
[10]	World Health Organization. Handbook for the use of digital technologies to support tuberculosis medication adherence. Geneva: World Health Organization, 2017.
[11]	徐红, 陆峰. 运用电子药盒管理肺结核患者依从性分析. 江苏预防医学, 2013, 24(1):51-52. doi: 10.3969/j.issn.1006-9070.2013.01.023. doi: 10.3969/j.issn.1006-9070.2013.01.023
[12]	葛夫莲, 徐文. 山东省基层医疗卫生机构资源配置效率影响因素分析. 中国药业, 2020, 29(4): 5-8. doi: 10.3969/j.issn.1006-4931.2020.04.002. doi: 10.3969/j.issn.1006-4931.2020.04.002
[13]	陈俊虎, 曾今诚, 王涛, 等. DOTS策略下广东省结核病患者发现及登记管理的定性分析. 结核病与肺部健康杂志, 2017, 6(4):332-335. doi: 10.3969/j.issn.2095-3755.2017.04.007. doi: 10.3969/j.issn.2095-3755.2017.04.007
[14]	张国钦, 傅衍勇, 钟达, 等. 肺结核患者对手机督导管理应用程序的使用意愿及影响因素分析. 结核病与肺部健康杂志, 2017, 6(4):322-326. doi: 10.3969/j.issn.2095-3755.2017.04.005. doi: 10.3969/j.issn.2095-3755.2017.04.005
[15]	Wang N, Guo L, Shewade HD, et al. Effect of using electronic medication monitors on tuberculosis treatment outcomes in China: a longitudinal ecological study. Infect Dis Poverty, 2021, 10(1): 29. doi: 10.1186/s40249-021-00818-3. doi: 10.1186/s40249-021-00818-3 pmid: 33731213

特征	登记数(8435例)	构成比(%)
性别
男性	6020	71.37
女性	2415	28.63
年龄组(岁)
3~19	520	6.16
20~39	1938	22.98
40~59	3442	40.81
60~95	2535	30.05
民族
汉族	8074	95.72
少数民族	361	4.28
职业
农牧民	4323	51.25
非农牧民	4112	48.75
户籍地^a
本地	7395	87.67
外地	1040	12.33
患者来源
因症检查^b	4103	48.65
转诊追踪	3883	46.03
其他来源^c	449	5.32
诊断结果
病原学阳性^d	4590	54.41
病原学阴性	3373	39.99
其他结果^e	472	5.60
治疗分类
初治	7839	92.93
复治	596	7.07

地区	登记例数	使用例数	使用率(%)
长春市	2834	1458	51.45
四平市	1097	527	48.04
辽源市	356	294	82.58
通化市	664	462	69.58
白山市	404	286	70.79
松原市	1030	880	85.44
白城市	804	359	44.65
延边州	600	487	81.17
公主岭市	413	300	72.64
梅河口市	233	178	76.39
合计	8435	5231	62.02

特征	登记例数	使用例数	使用率(%)	χ²值	P值
性别				2.265	0.132
男性	6020	3703	61.51
女性	2415	1528	63.27
年龄组(岁)				13.300	0.004
3~19	520	290	55.77
20~39	1938	1184	61.09
40~59	3442	2191	63.65
60~95	2535	1566	61.78
民族				34.671	<0.001
汉族	8074	4954	61.36
少数民族	361	277	76.73
职业				11.053	0.001
农牧民	4323	2755	63.73
非农牧民	4112	2476	60.21
户籍地^a				346.901	<0.001
本地	7395	4859	65.71
外地	1040	372	35.77
患者来源				173.736	<0.001
因症检查^b	4103	2305	56.18
转诊追踪	3883	2697	69.46
其他来源^c	449	229	51.00
诊断结果				162.395	<0.001
病原学阳性^d	4590	2875	62.64
病原学阴性	3373	2192	64.99
其他结果^e	472	164	34.75
治疗分类				158.071	<0.001
初治	7839	5005	63.85
复治	596	226	37.92

变量	赋值
因变量	未使用=0;使用=1
协变量
年龄组	3~19岁=1;20~39岁=2;40~59岁=3;60~95岁=4
民族	汉族=0;少数民族=1
职业	非农牧民=0;农牧民=1
户籍地	外地=0;本地=1
患者来源	其他来源=1;转诊追踪=2;因症检查=3
诊断结果	其他结果=1;病原学阴性=2;病原学阳性=3
治疗分类	复治=0;初治=1